运动强度会影响循环中的C1q/TNF相关蛋白质和利他类1度
Michihiro Kon1, Koichi Watanabe2
1Department of Health and Sports Sciences, Faculty of Health and Sports Sciences, Toyo University, Tokyo, Japan.
Clinical physiology and functional imaging
|November 14, 2025
概括
高强度耐力运动显著增加了CTRP3,CTRP9和FSTL1的循环水平,这些都与改善的代谢健康有关. 适度强度的运动没有显示这些效应,这表明强度对这些有益的运动诱导的变化很重要.
科学领域:
- 运动生理学 运动生理学
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
背景情况:
- 与中等强度运动相比,高强度耐力运动与较低的代谢性疾病死亡率有关.
- 潜在的机制,特别是特定细胞因子的作用,仍然不清楚.
- 已知细胞因子C1q/瘤亡因子相关蛋白 (CTRP) 3,CTRP9和莉斯类蛋白1 (FSTL1) 改善了代谢健康,并在运动期间分泌.
研究的目的:
- 研究运动强度对CTRP3,CTRP9和FSTL1.1循环度的影响.
- 为了确定高强度或中等强度的耐力运动是否对这些关键代谢细胞因子产生不同的影响.
主要方法:
- 十名健康男性参与了一项交叉研究,涉及中等强度 (50% VO2max) 和高强度 (75% VO2max) 骑自行车试验,与能量消耗相匹配.
- 血液样本是在运动前,运动后立即和运动后120分钟收集的.
- 使用标准化试验测量了CTRP3,CTRP9和FSTL1的度.
主要成果:
- 高强度运动 (HIE) 导致运动后与运动前水平相比,循环CTRP3,CTRP9和FSTL1显著增加.
- 中等强度运动 (MIE) 并没有导致这些细胞因子度的显著变化.
- 与对照 (休息) 试验相比,在HIE试验中,运动后CTRP3,CTRP9和FSTL1的增加显着更大.
结论:
- 在高强度耐力运动后,CTRP3,CTRP9和FSTL1的循环度显著增加.
- 运动强度在调节这些有益的代谢细胞因子的分泌中起着至关重要的作用.
- 这些发现表明,一种潜在的机制将高强度运动与通过特定的细胞因子反应改善代谢健康联系起来.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
470
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
470